Anda di halaman 1dari 3

Why Electronic Data Capture and Early Phase Clinical Trials

Considered As Unlikely Pair?

Now is a time when technology is truly embedded within


peoples daily lives, the adoption of modern technology within
clinical research has been a step forward for the sector. 15
years ago, Electronic Data Capture (EDC) in clinical research
was still a relatively rare entity. But, fast forward to todays
clinical trials and electronic data capture solutions have a
proven track record of supporting studies of all sizes and
complexities.

The potential gains from EDC are now well understood across
the clinical trials industry, including lowering long-term study
costs, minimizing errors, providing access to real-time data,
improved data access, and reducing trial duration. They also
supports patient-centric approach to research.

This says, while the value of EDC in late stage clinical research
is now well-established, adoption in early phase clinical trials
has been slow. Historically, early phase clinical trials, mainly
among smaller and mid-sized organizations chose paper-based
processes owing to shorter study durations and lower subject
counts, the expected initial setup cost of electronic data
capture systems and the extra training needed for study
teams, to mention only a few reasons. But its important for
researchers to understand that early phase research programs
could also significantly benefit from EDC application.

Benefits to EDC Solutions in Early Phase Clinical


Research

First, EDC solutions allow quicker patient recruitment and


approval to participate in the study. They also help faster and
more accurate collection of data, meaning errors and potential
issues can be detected much earlier, and the challenges that
first-in-man studies represent can be seen much quicker than
paper-based processes. By assessing the safety and efficacy of
information more quickly and efficiently via the supply of the
data in real-time, EDC solutions ultimately support moving a
new drug through the development process and to market
sooner.

Recent developments in technology also indicates setup and


training times have been drastically minimised. To mention, by
using an EDC system in Phase I of a clinical trial program,
sponsors will already have a validated system in place when it
comes to moving to the next phase of development, saving
valuable time and providing consistency.

Despite the recognized benefits, the reality is that adoption of


EDC has remained relatively less in early phase clinical trials.
But owing to advances in technology, many of the barriers that
prevented small and mid-size organizations from making the
switch have been removed.

New Electronic Data Capture Solutions for Phase I


Studies Expected to Accelerate Timelines and Improve
Data Quality

Worldwide is transitioning to implementation of a total EDC


solution for its Phase I studies, which will speed up how it
collects data, as well as give sponsors an opportunity to review
data in as it is generated, as a study progresses. Data is
electronically delivered from the collection device into the EDC
system where it could be viewed by way of customizable
reports. This paperless approach would help you to accelerate
your study timelines and is thought to give Worldwide and
study partners with higher data quality.

We conclude now.

Whichever way you want to take your career you do; CRB
Tech Solutions is here to guide you in your Clinical
Research Career. We conclude the discussion here. Stay
connected with us this space for more discussions.

In the competition of many organizations CRB Tech Solutions


developed a good name. It has earned a name in providing the
best training in Clinical Research.
Clinical research jobs in Pune are increasing and to fulfill
the current demand of the proficient candidates, you should
consider enhancing yourself with our clinical research training
program.

The Clinical Research review by CRB Tech Solutions will


guide you in considering a clinical research career in this
field

Anda mungkin juga menyukai